Description
EMPIGET LT Tablets 10mg + 5mg (28’s pack) combine Empagliflozin and Linagliptin to provide effective management of type 2 diabetes mellitus. Each tablet contains 10mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose excretion through the kidneys, and 5mg of Linagliptin, a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon levels.
This combination therapy supports improved blood sugar control, aids in weight management, and may reduce the risk of cardiovascular complications. The 28-tablet pack ensures a convenient supply for consistent treatment.
Manufactured under strict quality standards, EMPIGET LT Tablets guarantee safety, efficacy, and reliable therapeutic results. Patients should use the medication as prescribed and follow a balanced diet and exercise regimen.
Reviews
There are no reviews yet.